Font Size: a A A
Keyword [the antitumor mechanism]
Result: 1 - 20 | Page: 1 of 2
1. The Role Of Survivin In The Antitumor Mechanism Of Taxol And The Effect Of It's Antisense On The Development Of Gastric Carcinoma In Rats
2. Study On The Antitumor Mechanism Of Realgar Nanoparticles
3. The Effects Of KLT On Midbrain System Disease And The Antitumor Mechanism Of Cooperation With KLT, NDV And SW
4. Studies Of The Antitumor Mechanism Of DNA Targeting Molecules Aided By Molecular Modeling
5. The Antitumor Mechanism Of Cryptotanshinone In Human HepG2 Cells
6. Study Of The Antitumor Components In Helianthus Annuus L. Head And The Antitumor Mechanism
7. The Antitumor Mechanism Of The Effective Portion Extracted From Liriope Muscari (Decne.) Baily
8. Construction Of Multifunctional Nano-antibody And The Study Of The Antitumor Mechanism
9. The Antitumor Mechanism Of Phenanthroimidazole Derivatives And Ruthenium(Ⅱ) Complexes
10. The Antitumor Mechanism Of PAHDAA And Its Copper Complex In Hepatocellular Carcinoma Cells
11. The Antitumor Mechanism Of Sanguinarine Chloride In SCLC And The Mechanism Of Malignant Transformation Of BEAS-2B Cells Induced By Arsenic
12. The Antitumor Mechanism Of A Novel Diterpene Jaridon 6 From Isodon Rubescens On Gastric Cancer Resistant Cell MGC803/5-Fu
13. The Antitumor Mechanism Of Paclitaxel Combined With ABT-199
14. Study On The Clinical Efficacy Of Fuzhengkangai Prescription Combined With Chemotherapy For Advanced NSCLC And The Antitumor Mechanism Of Fuzhengkangai Prescription
15. The Antitumor Mechanism Of PAHDAA In Colon Carcinoma Cells
16. Study On The Antitumor Mechanism Of LINC00595 In Colorectal Cancer
17. Study On The Antitumor Mechanism Of Green Tea Polyphenol EGCG And The Investigation On EGCG-NPs Reduce The Resistance Of EGFR-TKIs In Non-small Cell Lung Cancer
18. Study Of The Antitumor Mechanism Of Monomeric Compound SZ-NCI-C Against Ovarian Cancer
19. Structure-activity Relationship Of 2,6-disubstituted-3h-imidazo[4,5-b]Pyridine Derivatives And The Antitumor Mechanism And Druggability Evaluation Of GG041104
20. The Antitumor Mechanism Of PARP Inhibitor Combined With CDK4/6 Inhibitor In P53-wildtype Gastrointestinal Cancer
  <<First  <Prev  Next>  Last>>  Jump to